ARCA Biopharma Inc (ABIO) - Earnings growth forecast for next year

Brandmark of ARCA Biopharma Inc (ABIO)

ARCA Biopharma (ABIO) is a biotech company whose resilience depends on clinical trial outcomes, and whose asset structure is currently transforming to attract new partners. The history of forward earnings per share valuations clearly demonstrates these changes, where the 0.00 mark reflects current market expectations. Strategic alliances with medical centers and M&A deals are creating the necessary synergistic effect to accelerate the development of cardiovascular drugs.

ARCA Bio (ABIO): Expected net earnings per share growth next year from 07/04/2022 to 09/03/2024

ARCA Biopharma Inc - analytical breakdowns and key metrics (ABIO)

- share price and consensus valuation forecast:
- market capitalization indicators:
Basic company analysis:ABIO, ARCA Biopharma Inc
Finished products of ARCA Biopharma, Inc.

For ARCA Biopharma (ABIO), which is developing precision therapy for cardiomyopathies, the target net income per share growth rate reflects market expectations regarding the commercialization of its R&D potential. This metric aggregates analyst forecasts for EPS dynamics, where any deviation from a horizontal trend signals a revision of the issuer's fundamental valuation models, determining either an entry point or the risk of a capital correction.

Competitor analysis for ARCA Biopharma

REGN (Regeneron Pharmaceuticals, Inc.) - Earnings growth forecast for next year|IRTC: Expected earnings per share trend next year|Expected earnings per share growth for next year LNTH (lantheus.com)|Net earnings per share growth forecast for next year MLYS (Mineralys Therapeutics Inc)|Net earnings per share growth forecast for next year HeartFlow HTFL|KMTS - Expected earnings per share growth for next year|ESPR: Expected earnings per share growth for next year|Expected net earnings per share growth next year amarincorp.com|AVR: Earnings growth forecast for next year|Expected net earnings per share growth next year Tenaya Therapeutics Inc (TNYA)|Expected earnings per share growth for next year CVRX|Milestone Pharma - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Cardiol Therapeutics Inc (CRDL)|HeartBeam, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year TENX (Tenax Therapeutics Inc)|Earnings growth forecast for next year Adagio Medical Holdings, Inc. ADGM|BCDA: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Catheter Precision Corporation VTAK|ACST: Earnings growth forecast for next year|Net earnings per share change forecast for next year AVTE (Aerovate Therapeutics)|VERV (Verve Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year Windtree Therapeutics, Inc. WINT